Expanding the arsenal: Metformin for the treatment of triple-negative breast cancer?

 Abstract

Comment on: Metformin induces unique biological and molecular responses in triple negative breast cancer cells.

Bolin Liu, Zeying Fan, Susan M. Edgerton, Xin-Sheng Deng, Irina N. Alimova, Stuart E. Lind, et al. Cell Cycle 2009; 8:2031–40.


Full Text Options
Article
Metrics
 Share
 Info
Pages
2681 - 2684
doi
10.4161/cc.8.17.9502
Type
Cell Cycle News & Views
 Metrics
 Cite This Article
 Permissions
 Permissions
 Reprints
Expanding the arsenal: Metformin for the treatment of triple-negative breast cancer?